Personal CFO Solutions’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $922K | Sell |
1,756
-72
| -4% | -$37.8K | 0.17% | 122 |
|
|
2025
Q1 | $1.16M | Sell |
1,828
-24
| -1% | -$15.2K | 0.24% | 84 |
|
|
2024
Q4 | $1.32M | Buy |
1,852
+1,291
| +230% | +$920K | 0.26% | 74 |
|
|
2024
Q3 | $590K | Buy |
561
+33
| +6% | +$34.7K | 0.08% | 225 |
|
|
2024
Q2 | $555K | Buy |
528
+18
| +4% | +$18.9K | 0.09% | 232 |
|
|
2024
Q1 | $491K | Sell |
510
-16
| -3% | -$15.4K | 0.08% | 257 |
|
|
2023
Q4 | $462K | Sell |
526
-64
| -11% | -$56.2K | 0.08% | 245 |
|
|
2023
Q3 | $486K | Sell |
590
-2
| -0.3% | -$1.65K | 0.1% | 201 |
|
|
2023
Q2 | $425K | Sell |
592
-16
| -3% | -$11.5K | 0.09% | 240 |
|
|
2023
Q1 | $500K | Buy |
608
+28
| +5% | +$23K | 0.1% | 196 |
|
|
2022
Q4 | $418K | Sell |
580
-146
| -20% | -$105K | 0.09% | 214 |
|
|
2022
Q3 | $500K | Sell |
726
-31
| -4% | -$21.4K | 0.13% | 154 |
|
|
2022
Q2 | $447K | Buy |
757
+4
| +0.5% | +$2.36K | 0.1% | 175 |
|
|
2022
Q1 | $526K | Sell |
753
-353
| -32% | -$247K | 0.1% | 190 |
|
|
2021
Q4 | $698K | Buy |
1,106
+459
| +71% | +$290K | 0.13% | 151 |
|
|
2021
Q3 | $392K | Buy |
+647
| New | +$392K | 0.08% | 223 |
|
|
2021
Q1 | – | Sell |
-1,701
| Closed | -$822K | – | 445 |
|
|
2020
Q4 | $822K | Buy |
1,701
+85
| +5% | +$41.1K | 0.2% | 104 |
|
|
2020
Q3 | $1K | Sell |
1,616
-100
| -6% | -$62 | 0.33% | 112 |
|
|
2020
Q2 | $1.07M | Buy |
1,716
+11
| +0.6% | +$6.86K | 0.32% | 73 |
|
|
2020
Q1 | $833K | Buy |
1,705
+122
| +8% | +$59.6K | 0.3% | 77 |
|
|
2019
Q4 | $593K | Sell |
1,583
-147
| -8% | -$55.1K | 0.17% | 126 |
|
|
2019
Q3 | $480K | Buy |
+1,730
| New | +$480K | 0.19% | 134 |
|